Clinical Trials Directory

Trials / Terminated

TerminatedNCT02204709

Disease Risk Reduction and Omega-3 Rich Rainbow Trout (Fish for Health)

Disease Risk Reduction and n-3 Rich Rainbow Trout (Fish for Health)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
USDA Grand Forks Human Nutrition Research Center · Federal
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how eating fish raised to have different levels of omega-3 fatty acids will reduce cardiovascular risk markers in people with elevated cardiovascular risk.

Detailed description

Consumption of fish high in long chain omega-3 fatty acids (LCn3) is associated with reduction of cardiovascular disease (CVD) risk. CVD is a major cause of death in the United States. The current obesity epidemic contributes significantly to elevated CVD risk by increasing inflammation and platelet dysfunction. Prevention of CVD is a public health goal and comprises several avenues of action, of which inclusion of LCn3-rich fish in the diet may be one of the most effective. Obese participants will participate in a double blind, randomized, cross-over designed trial in which they will consume twice-weekly a prepared meal containing diploid (2N) farmed rainbow trout, triploid (3N) farmed rainbow trout containing higher levels of LCn3, or tilapia, a low LCn3 fish.

Conditions

Interventions

TypeNameDescription
OTHER2N TroutDiploid/2N trout source
OTHER3N TroutTriploid/3N trout source
OTHERTilapiaTilapia/control fish source

Timeline

Start date
2015-06-01
Primary completion
2020-03-25
Completion
2020-03-25
First posted
2014-07-30
Last updated
2022-08-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02204709. Inclusion in this directory is not an endorsement.